Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H15NO3 |
Molecular Weight | 209.2417 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2OCOC2=CC(CC(C)N)=C1
InChI
InChIKey=YQYUWUKDEVZFDB-UHFFFAOYSA-N
InChI=1S/C11H15NO3/c1-7(12)3-8-4-9(13-2)11-10(5-8)14-6-15-11/h4-5,7H,3,6,12H2,1-2H3
Molecular Formula | C11H15NO3 |
Molecular Weight | 209.2417 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P28223 Gene ID: 3356.0 Gene Symbol: HTR2A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17203365 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:22:55 GMT 2023
by
admin
on
Fri Dec 15 15:22:55 GMT 2023
|
Record UNII |
RG7FY73ZAA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
PiHKAL
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-MMDA
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB01442
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY | |||
|
13674-05-0
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY | |||
|
DTXSID50860757
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY | |||
|
MMDA (DRUG)
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY | |||
|
RG7FY73ZAA
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY | |||
|
26175
Created by
admin on Fri Dec 15 15:22:55 GMT 2023 , Edited by admin on Fri Dec 15 15:22:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|